Cargando…
miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
BACKGROUND: Chemotherapeutic insensitivity and tumor cell invasiveness are major obstacles to effectively treating muscle-invasive bladder cancer (MIBC). Recent reports show that microRNAs (miRNAs) play an important role in the chemotherapeutic response and disease progression of MIBC. Therefore, he...
Autores principales: | Lei, Ye, Hu, Xiheng, Li, Bin, Peng, Minyuan, Tong, Shiyu, Zu, Xiongbing, Wang, Zhi, Qi, Lin, Chen, Minfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199406/ https://www.ncbi.nlm.nih.gov/pubmed/25287716 http://dx.doi.org/10.12659/MSM.891340 |
Ejemplares similares
-
miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells
por: Lei, Ye, et al.
Publicado: (2015) -
Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy
por: Chen, Jinbo, et al.
Publicado: (2016) -
ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion
por: Wu, Longxiang, et al.
Publicado: (2019) -
Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy
por: Long, Xingbo, et al.
Publicado: (2016) -
Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer
por: Li, Yangle, et al.
Publicado: (2019)